Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

PDE4 inhibitor developed at Celltech superior to available antiasthmatic agents in rabbit model

Nov. 27, 1998

Montelukast shows synergistic efficacy with antihistamines in allergic rhinitis

Nov. 27, 1998

Targeted Genetics and Medeva form collaboration to develop CF treatment

Nov. 27, 1998

Noval antiasthmatic agent from Takeda with dual antiinflammatory and bronchodilating effects

Nov. 26, 1998

FK-3657: clinical candidate from novel class of nonpeptide BK antagonists

Nov. 26, 1998

NOS inhibitors claimed by Astra for use in inflammation and pain

Nov. 26, 1998

Pfizer claims new series for inhibiting PDE4 and TNF production

Nov. 26, 1998

Zyrtec available in Japan through UCB licensees

Nov. 26, 1998

Study points to improved efficacy with levalbuterol vs. racemic albuterol

Nov. 26, 1998

AxyS describes new serine protease inhibitors for inflammatory disorders

Nov. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...